Regorafenib (BAY 73-4506) monohydrate is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRbeta, Kit, RET and Raf-1, respectively. Regorafenib monohydrate shows very robust antitumor and antiangiogenic activity[1].
Molecular Weight:
500.83
Purity:
99.94
CAS Number:
[1019206-88-2]
Formula:
C21H17ClF4N4O4
Target:
Autophagy,c-Kit,FGFR,PDGFR,Raf,RET,Tie,VEGFR
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
